Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;11(1):1-15.
doi: 10.21037/acs-2021-taes-25.

Thoracic endovascular repair of chronic type B aortic dissection: a systematic review

Michael L Williams  1   2   3 , Madeleine de Boer  4 , Bridget Hwang  2 , Bruce Wilson  2 , John Brookes  2   5 , Nicholas McNamara  6 , David H Tian  7 , Timothy Shiraev  4 , Ourania Preventza  8   9
Affiliations

Thoracic endovascular repair of chronic type B aortic dissection: a systematic review

Michael L Williams et al. Ann Cardiothorac Surg. 2022 Jan.

Abstract

Background: At present, the optimal management strategy for chronic type B aortic dissection (CTBAD) remains unknown, as equipoise remains regarding medical management versus endovascular treatment versus open surgery. However, the results over recent years of thoracic endovascular aortic repair (TEVAR) in CTBAD appear promising. The aim of this systematic review was to provide a comprehensive analysis of the available data reporting outcomes and survival rates for TEVAR in CTBAD.

Methods: Electronic searches of six databases were performed from inception to April 2021. All studies reporting outcomes, specifically 30-day mortality rates, for endovascular repair of CTBAD were identified. Relevant data were extracted, and a random-effects meta-analysis of proportions or means was performed to aggregate the data. Survival data were pooled using data derived from original Kaplan-Meier curves, which allows reconstruction of individual patient data.

Results: Forty-eight studies with 2,641 patients were identified. Early (<30 days) all-cause and aortic-related mortality rates were low at 1.6% and 0.5%, respectively. Incidence of retrograde type A dissection in the post-operative period was only 1.4%. There were also low rates of cerebrovascular accidents and spinal cord injury (1.1% and 0.9%, respectively). Late follow-up all-cause mortality was 8.0%, however, late aortic-related mortality was only 2.4%. Reintervention rates were 10.1% for endovascular and 6.7% for surgical reintervention. Pooled rates of overall survival at 1-, 3-, 5- and 10-year were 91.5%, 84.7%, 77.7% and 56.3%, respectively.

Conclusions: The significant heterogeneity in the available evidence and absence of consensus reporting standards are important considerations and concern when interpreting the data. Evaluation of the evidence suggests that TEVAR for CTBAD is a safe procedure with low rates of complications. However, the optimal treatment strategy for CTBAD remains debatable and requires further research. Evidence from high-quality registries and clinical trials are required to address these challenges.

Keywords: Chronic type B aortic dissection (CTBAD); descending thoracic aorta; thoracic endovascular aortic repair (TEVAR).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Dr. OP provides consultation for and participates in clinical trials with Medtronic and W.L. Gore & Associates. The other authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
PRISMA flow-chart summarizing the search strategy for relevant publications.
Figure 2
Figure 2
Aggregated overall survival after TEVAR in CTBAD (shaded region represents 95% CI). TEVAR, thoracic endovascular aortic repair; CTBAD, chronic type B aortic dissection.
Figure 3
Figure 3
Aggregated aorta-related survival after TEVAR in CTBAD (shaded region represents 95% CI). TEVAR, thoracic endovascular aortic repair; CTBAD, chronic type B aortic dissection.
Figure 4
Figure 4
Aggregated freedom from re-intervention after TEVAR in CTBAD (shaded region represents 95% CI). TEVAR, thoracic endovascular aortic repair; CTBAD, chronic type B aortic dissection.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Giugliano G, Spadera L, De Laurentis M, et al. Chronic aortic dissection: still a challenge. Acta Cardiol 2009;64:653-63. 10.2143/AC.64.5.2042696 - DOI - PubMed
    1. Nienaber CA, Divchev D, Palisch H, et al. Early and late management of type B aortic dissection. Heart 2014;100:1491-7. 10.1136/heartjnl-2013-305133 - DOI - PubMed
    1. McGee EC, Jr, Pham DT, Gleason TG. Chronic descending aortic dissections. Semin Thorac Cardiovasc Surg 2005;17:262-7. 10.1053/j.semtcvs.2005.06.013 - DOI - PubMed
    1. Karthikesalingam A, Holt PJ, Hinchliffe RJ, et al. The diagnosis and management of aortic dissection. Vasc Endovascular Surg 2010;44:165-9. 10.1177/1538574410362118 - DOI - PubMed
    1. Elsayed RS, Cohen RG, Fleischman F, et al. Acute Type A Aortic Dissection. Cardiol Clin 2017;35:331-45. 10.1016/j.ccl.2017.03.004 - DOI - PubMed